ArriVent BioPharma (AVBP) Current Leases (2023 - 2026)
ArriVent BioPharma's (AVBP) quarterly Current Leases came in at $99000.0 in Q1 2026, down 28.26% year-on-year from $138000.0 in Q1 2025, and up 607.14% quarter-over-quarter from $14000.0 in Q4 2025.
ArriVent BioPharma (AVBP) Current Leases (2023 - 2026) Analysis & Trends
ArriVent BioPharma has disclosed Current Leases across 4 years of filings, most recently posting $99000.0 for Q1 2026.
- Current Leases for Q1 2026 came in at $99000.0, down 28.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $99000.0 (down 28.26% YoY), and the FY2025 annual result was $14000.0, down 91.36% from the prior year.
- Current Leases came in at $99000.0 for Q1 2026 at ArriVent BioPharma, up from $14000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $162000.0 in Q4 2024 to a low of $14000.0 in Q4 2025.
- The 4-year median for Current Leases is $139000.0 (2023), against an average of $116300.0.
- Across the five-year window, Current Leases climbed 15.71% in 2024 and tumbled 91.36% in 2025, its largest moves.
- ArriVent BioPharma's Current Leases stood at $140000.0 in 2023, then rose by 15.71% to $162000.0 in 2024, then sank by 91.36% to $14000.0 in 2025, then soared by 607.14% to $99000.0 in 2026.
- The last three Current Leases figures came in at $99000.0 (Q1 2026), $14000.0 (Q4 2025), and $56000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | ArriVent BioPharma | 1.37 Bn | 1.37 Bn | - | 99,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99,000.00 |
| Dec 31, 2025 | 14,000.00 |
| Sep 30, 2025 | 56,000.00 |
| Jun 30, 2025 | 98,000.00 |
| Mar 31, 2025 | 138,000.00 |
| Dec 31, 2024 | 162,000.00 |
| Sep 30, 2024 | 157,000.00 |
| Jun 30, 2024 | 152,000.00 |
| Mar 31, 2024 | 147,000.00 |
| Dec 31, 2023 | 140,000.00 |